BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34229558)

  • 1. Design, synthesis, and biological evaluation of 5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1
    Wu J; Hu H; Ao M; Cui Z; Zhou X; Qin J; Guo Y; Chen J; Xue Y; Fang M
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1436-1453. PubMed ID: 34229558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of 5-((8-methoxy-2-methylquinolin-4-yl)amino)-1H-indole-2-carbohydrazide derivatives as novel Nur77 modulators.
    Li B; Yao J; Guo K; He F; Chen K; Lin Z; Liu S; Huang J; Wu Q; Fang M; Zeng J; Wu Z
    Eur J Med Chem; 2020 Oct; 204():112608. PubMed ID: 32717483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of 2-oindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cells.
    Eldehna WM; Abo-Ashour MF; Al-Warhi T; Al-Rashood ST; Alharbi A; Ayyad RR; Al-Khayal K; Abdulla M; Abdel-Aziz HA; Ahmad R; El-Haggar R
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):319-328. PubMed ID: 33345633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
    Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
    Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5-carbohydrazide derivatives.
    Zhang D; Wang G; Zhao G; Xu W; Huo L
    Eur J Med Chem; 2011 Dec; 46(12):5868-77. PubMed ID: 22000925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
    Sbenati RM; Zaraei SO; El-Gamal MI; Anbar HS; Tarazi H; Zoghbor MM; Mohamood NA; Khakpour MM; Zaher DM; Omar HA; Alach NN; Shehata MK; El-Gamal R
    Eur J Med Chem; 2021 Jan; 210():113081. PubMed ID: 33310290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.
    Liu QQ; Lu K; Zhu HM; Kong SL; Yuan JM; Zhang GH; Chen NY; Gu CX; Pan CX; Mo DL; Su GF
    Eur J Med Chem; 2019 Mar; 165():293-308. PubMed ID: 30685528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Design of Potent Nicotinamide Phosphoribosyltransferase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities.
    Bai J; Liao C; Liu Y; Qin X; Chen J; Qiu Y; Qin D; Li Z; Tu ZC; Jiang S
    J Med Chem; 2016 Jun; 59(12):5766-79. PubMed ID: 27224875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel indole hydrazide derivatives: Synthesis and their antiproliferative activities through inducing apoptosis and DNA damage.
    Kilic-Kurt Z; Acar C; Ergul M; Bakar-Ates F; Altuntas TG
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000059. PubMed ID: 32419228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of indole-based chalcones as inducers of methuosis, a novel type of nonapoptotic cell death.
    Robinson MW; Overmeyer JH; Young AM; Erhardt PW; Maltese WA
    J Med Chem; 2012 Mar; 55(5):1940-56. PubMed ID: 22335538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer.
    Guo Y; Zhao Y; Wang G; Chen Y; Jiang Y; Ouyang L; Liu B
    Eur J Med Chem; 2018 Jan; 143():402-418. PubMed ID: 29202403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of new indole containing biaryl derivatives as potent antiproliferative agents.
    Yuan S; Feng SQ; Li AQ; Zuo JH; Zhang DQ; Xing YJ; Xie Z; Yu B; Liu HM
    Bioorg Chem; 2021 May; 110():104821. PubMed ID: 33812156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel 4-thiazolidinone derivatives with promising anti-breast cancer activity: Synthesis, characterization, in vitro and in vivo results.
    Tahmasvand R; Bayat P; Vahdaniparast SM; Dehghani S; Kooshafar Z; Khaleghi S; Almasirad A; Salimi M
    Bioorg Chem; 2020 Nov; 104():104276. PubMed ID: 32992280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of 1H-pyrazolo [3,4-d]pyrimidine derivatives as PAK1 inhibitors that trigger apoptosis, ER stress and anti-migration effect in MDA-MB-231 cells.
    Zhang J; Zou L; Tang P; Pan D; He Z; Yao D
    Eur J Med Chem; 2020 May; 194():112220. PubMed ID: 32222676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of methylenehydrazine-1-carboxamide derivatives with (5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole scaffold: Novel potential CDK9 inhibitors.
    Hu H; Wu J; Ao M; Zhou X; Li B; Cui Z; Wu T; Wang L; Xue Y; Wu Z; Fang M
    Bioorg Chem; 2020 Sep; 102():104064. PubMed ID: 32653610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and identification of a novel skeleton of N-(pyridin-3-yl) proline as a selective CDK4/6 inhibitor with anti-breast cancer activities.
    Liang JW; Li WQ; Nian QY; Xie SH; Yang L; Meng FH
    Bioorg Chem; 2022 Feb; 119():105547. PubMed ID: 34906858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
    Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N
    Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of indole-2-carbohydrazides and thiazolidinyl-indole-2-carboxamides as potent tubulin polymerization inhibitors.
    Kazan F; Yagci ZB; Bai R; Ozkirimli E; Hamel E; Ozkirimli S
    Comput Biol Chem; 2019 Jun; 80():512-523. PubMed ID: 31185422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, anticancer and antioxidant activities of some novel N-(benzo[d]oxazol-2-yl)-2-(7- or 5-substituted-2-oxoindolin-3-ylidene) hydrazinecarboxamide derivatives.
    Gudipati R; Anreddy RN; Manda S
    J Enzyme Inhib Med Chem; 2011 Dec; 26(6):813-8. PubMed ID: 21476831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.